Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(10%)
Results Posted
20%(1 trials)

Phase Distribution

Ph not_applicable
4
40%
Ph phase_3
2
20%
Ph phase_2
2
20%
Ph phase_4
2
20%

Phase Distribution

0

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
2(20.0%)
Phase 4Post-market surveillance
2(20.0%)
N/ANon-phased studies
4(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(5)
Other(3)

Detailed Status

Completed5
unknown3
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (20.0%)
Phase 32 (20.0%)
Phase 42 (20.0%)
N/A4 (40.0%)

Trials by Status

recruiting110%
completed550%
not_yet_recruiting110%
unknown330%

Recent Activity

1 active trials
Showing 5 of 10
recruitingnot_applicable

Effects of Rectal Indomethacin Suppository on Postoperative CRBD in Patients Undergoing LRP

NCT07607990
completedphase_3

Prophylaxis of Post-ERCP Acute Pancreatitis

NCT05381428
not_yet_recruitingphase_2

Efficacy and Safety of Parecoxib vs. Indomethacin in Preventing Post-ERCP Pancreatitis

NCT06623513
completednot_applicable

The Optimal Dose of Indomethacin Suppository for Preventing Post-ERCP Pancreatitis

NCT06031363
unknownphase_2

Efficacy of Rectal Indomethacin in Prevention of Post-pancreatectomy Acute Pancreatitis

NCT05722548
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07607990Not Applicable

Effects of Rectal Indomethacin Suppository on Postoperative CRBD in Patients Undergoing LRP

Recruiting
NCT05381428Phase 3

Prophylaxis of Post-ERCP Acute Pancreatitis

Completed
NCT06623513Phase 2

Efficacy and Safety of Parecoxib vs. Indomethacin in Preventing Post-ERCP Pancreatitis

Not Yet Recruiting
NCT06031363Not Applicable

The Optimal Dose of Indomethacin Suppository for Preventing Post-ERCP Pancreatitis

Completed
NCT05722548Phase 2

Efficacy of Rectal Indomethacin in Prevention of Post-pancreatectomy Acute Pancreatitis

Unknown
NCT05109143Not Applicable

Efficacy of Rectal Indomethacin in Prevention of Post-operative Pancreatitis After Pancreaticoduodenectomy

Completed
NCT02797067Phase 4

Rectal Indomethacin to Prevent Post ESWL-pancreatitis

Completed
NCT04964180Not Applicable

Rectal Indomethacin Versus Intraperitoneal Lidocaine for Analgesia After Laparoscopic Cholecystectomy

Completed
NCT03708458Phase 4

Pharmacological Prophylaxis of Post- Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis

Unknown
NCT01742689Phase 3

Analgesic Efficacy of Intranasal Desmopressin in Acute Renal Colic

Unknown

All 10 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
10